BUY Allied Blenders and Distillers Ltd — Nomura India Research
byNomura India ResearchHorizon: NA (inferred 1 year)30 Oct 2026via ET Now (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·30 Oct · today
3 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · same horizon·29 Oct · yesterday
Allied Blenders Q2 Results: Profit rises 9.7% to Rs 69 crore, revenue up 6.8%
NewsEt-Markets·27 Oct · 2d ago
Allied Blenders and Distillers reported Q2FY27 financial results with income from operations at 1,152 crore, up 15.8% y-o-y, and record quarterly sales volumes of 10 million cases.
BSE · Company Update·27 Oct · 3d ago
Allied Blenders and Distillers has commenced commercial operations at its new malt distillery in Rangapur, Telangana, with an annual capacity of 4.4 million BL to support vertical integration.
BSE · Company Update·22 Oct · 1w ago
Unaudited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Half Year ended September 30, 2026.
BSE · Board Meeting·27 Oct · 3d ago
An arbitrator ruled that no valid arbitration agreement exists between the company and the Canteen Stores Department regarding a dispute over debit notes, terminating the current proceedings.
NSE · Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company·1 Oct · 4w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Allied Blenders and Distillers
- BUY — ICICI Securities29 Oct 2026 · ~1 year · target ₹830 · Active
- BUY — Chandan Taparia, Motilal Oswal15 Oct 2026 · ~1 year · target ₹850 · SL hit
- BUY — Gaurav Sharma, Globe Capital Market15 Oct 2026 · ~2 weeks · target ₹770 · SL hit
- BUY — Chandan Taparia, Motilal Oswal15 Oct 2026 · ~2 weeks · target ₹777 · SL hit
- BUY — Chandan Taparia, Motilal Oswal14 Oct 2026 · Next day · target ₹770 · Expired
More from Nomura India Research
- BUY Restaurant Brands Asia30 Oct 2026 · ~1 year · target ₹106 · Active
- BUY Trent30 Oct 2026 · ~1 year · target ₹3,410 · Active
- BUY Medplus Health Services30 Oct 2026 · ~1 year · target ₹915 · Active
- BUY United Spirits30 Oct 2026 · ~1 year · target ₹1,600 · Active
- SELL ACC30 Oct 2026 · ~1 year · target ₹1,000 · Active

